Clinical Trial Update: Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating an ultradian subcutaneous hydrocortisone infusion for Addison's disease and congenital adrenal hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Addison Disease
• Congenital Adrenal Hyperplasia

Drugs mentioned

• Ultradian Subcutaneous Hydrocortisone Infusion (hydrocortisone)

Snippet

Sponsor: Haukeland University Hospital | Conditions: Addison Disease, Adrenal Hyperplasia Congenital | Phase 1, Phase 2 | Status: COMPLETED